[00:00:04] Doug McIntyre: Lee, I wanna tell you what I think investors need to take into account now.
24/7 concierge: Zoom's agentic AI and virtual agent now extends to Zoom Phone, helping businesses capture more calls and opportunities — Neutral
ZM GlobeNewsWire — August 18, 2025Zoom Virtual Agent expands to Zoom Phone, enabling a new concierge use case that delivers personalized support with agentic concierge capabilities to automate routine calls and streamline frontline service across departments Zoom AI Companion enhances agentic scheduling to coordinate meetings end-to-end, finding the best time, contacting attendees, tracking responses, and recommending next steps without the back-and-forth Zoom Hub launches, providing a centralized workspace to create, find, and manage Zoom files Zoom Team Chat adds AI Companion to mobile for easier catch-up, and quick document summaries without needing to open the file in the Zoom Workplace desktop app, saving time and …
Stock Market Live August 18: S&P 500 (VOO) Rally Pauses After Inconclusive Russia Talks — Negative
VOO 24/7 Wall Street — August 18, 2025An Alaska meeting between President Trump and President Putin Friday ended without major announcements, and failed to end fighting in Ukraine.
Freightos Limited (CRGO) Reports Q2 Loss, Tops Revenue Estimates — Neutral
CRGO Zacks Investment Research — August 18, 2025Freightos Limited (CRGO) came out with a quarterly loss of $0.09 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.11 per share a year ago.
S&P 500 futures edge lower as Trump-Zelensky meeting looms — Neutral
IVV SPLG SPXL SPY SSO UPRO VOO Proactive Investors — August 18, 20258:45am: Geopolitics, Fed in focus Stock futures leaned lower early Monday as investors braced for a week where geopolitics could set the tone. S&P 500 futures slipped about 0.1%, Dow futures hovered near flat, and contracts on the Nasdaq 100 edged down nearly 0.2%.
Duolingo Stock Rises. Why AI Fears Are Overblown, Analysts Say. — Positive
DUOL Barrons — August 18, 2025Analysts at Citi Research and KeyBanc Capital Markets issued buy-equivalent ratings for the stock.
Duke Energy supports local conservation efforts with $550,000 in funding for North Carolina environmental impact programs — Neutral
DUK PRNewsWire — August 18, 2025Grants will fund programs focused on protecting and improving natural environments, biodiversity and community resilience Funds will benefit 19 environmental impact programs, including conservation groups and community-led initiatives Over $6.6 million in environmental impact grants have been awarded over the past five years CHARLOTTE, N.C. , Aug. 18, 2025 /PRNewswire/ -- Duke Energy today announced $550,000 in grants for environmental impact programs in North Carolina.
Novo Nordisk said on Monday that it was launching a new offer for self-paying type 2 diabetes patients to access authentic Ozempic for $499 per month.
DigiAsia Indonesia Revamps Strategy, Shifts from Super App to Simple App to Strengthen Embedded Finance Growth — Neutral
FAAS Newsfile Corp — August 18, 2025Jakarta, Indonesia--(Newsfile Corp. - August 18, 2025) - DigiAsia Bios (NASDAQ: FAAS), a leading embedded finance provider in Indonesia, today announced a strategic shift in its business model, moving away from a "super app" approach toward a streamlined "simple app" strategy. This transition reflects the company's renewed focus on enhancing core financial services and scaling its embedded wallet offering for third-party platforms.
GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month — Neutral
GDRX Business Wire — August 18, 2025SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that via a collaboration with Novo Nordisk, all strengths of Ozempic® (semaglutide) and Wegovy® (semaglutide) pens are available to eligible self-paying patients for $499-per-month through GoodRx, effective today. This collaboration significantly lowers the price available on GoodRx for two of the most in-demand GLP-1 medications nationwide, expanding access for.
Nextracker Releases Fiscal Year 2025 Sustainability Report — Neutral
NXT Business Wire — August 18, 2025FREMONT, Calif.--(BUSINESS WIRE)--Nextracker (Nasdaq: NXT), a leading solar technology platform provider, today published its fiscal year 2025 Sustainability Report, highlighting significant progress in advancing the company's environmental, social, and governance (ESG) initiatives across its global operations. This second annual publication reinforces the company's commitment to building a more sustainable, inclusive, and transparent energy industry. The report aligns with the Sustainability A.
UBS Hires Ryan Rozniakowski as Senior Market Director for Northern New Jersey — Neutral
UBS Business Wire — August 18, 2025PARAMUS, N.J.--(BUSINESS WIRE)--UBS is pleased to announce the appointment of Ryan Rozniakowski as Senior Market Director for Northern New Jersey within the Greater New York Metro Market. Ryan leads UBS's Paramus office, the firm's largest branch in New Jersey, where he is responsible for overseeing strategic growth, driving profitability, and leading a team of more than 130 employees. His appointment underscores the importance of Paramus as a critical business within the Greater New York Metro.
Innoviz: New Ride-Sharing Service Rollout Provides Possible Upside Catalyst — Positive
INVZ Seeking Alpha — August 18, 2025Innoviz is an undervalued LiDAR company lagging behind its peers in stock performance. Stock price correction could be driven by its Volkswagen partnership and expansion into industrial markets. The low market cap and huge addressable market create a favorable risk/reward profile.
Google announces Tennessee as site for small modular nuclear reactor — Positive
GOOG GOOGL Reuters — August 18, 2025Google , with Kairos Power, has selected Tennessee as the site of an advanced nuclear power plant that is expected to supply electricity to the Big Tech company's data centers in the U.S. southeast starting in 2030, the companies said on Monday.
Undercovered Dozen: BrightSpire Capital, Vertex Pharmaceuticals, Adobe And More — Positive
ADBE VRTX Seeking Alpha — August 18, 2025This week's Undercovered Dozen spotlights 12 lesser-known stocks and ETFs, offering unique investment opportunities across gold, biotech, income, and tech sectors. B2Gold and Vertex Pharmaceuticals stand out as strong buys, driven by robust fundamentals, sector leadership, and clear growth catalysts for 2025 and beyond. Caution is urged on popular income-focused ETFs like SPYI and ULTY, as structural flaws and capped upside may limit long-term wealth compounding.
Chevron & Exxon Near Landmark Deal to Unlock Algeria's Gas Reserves — Positive
CVX XOM Zacks Investment Research — August 18, 2025CVX and Exxon Mobil approach major shale gas deals in Algeria, aiming to boost output, strengthen Europe's energy security and expand global influence.
AEVA Collapses 59% in a Month - Too Speculative to Hold Now? — Negative
AEVA Zacks Investment Research — August 18, 2025Aeva Technologies reels from steep losses and fierce competition as its fragile finances cast doubt on future growth.
4 Low-Beta Defensive Stocks to Bank on as Consumer Sentiment Plummets — Neutral
DEO FTS NJR OGS Zacks Investment Research — August 18, 2025As consumer sentiment weakens and inflation fears grow, Fortis, NJR, ONE Gas and Diageo emerge as attractive low-beta, dividend-paying plays.
Wall Street analyst updates UnitedHealth stock after Buffett's $1.6 billion stake — Neutral
UNH Finbold — August 18, 2025Bank of America Securities has updated its outlook on UnitedHealth Group (NYSE: UNH), maintaining a ‘Neutral' rating while raising its price target to $325 from $290.
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients — Positive
NVO CNBC — August 18, 2025Novo Nordisk said it now offers cash-paying U.S. patients its blockbuster diabetes treatment Ozempic for less than half its monthly list price through multiple platforms. Patients can pay $499 in cash per month for three dose sizes of Ozempic through the drug's official website, Novo Nordisk's patient assistance program, the company's recently launched direct-to-consumer online pharmacy and drug savings company GoodRx, among other platforms.